Added to YB: 2026-09-18
Pitch date: 2026-09-15
VME.DE [bullish]
Viromed Medical AG
Author Info
PPinvest is an Ex-Citibanker who shares stock pitches in their newsletter. Sign up for the newsletter.
Company Info
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology.
Market Cap
EUR 114.8M
Pitch Price
N/A
Price Target
21.18
Dividend
N/A
EV/EBITDA
-379.52
P/E
189.83
EV/Sales
22.49
Sector
Health Care Providers and Services
Category
special_situation
My Viromed bingo card and what could the stock be worth if PulmoPlas works?
VME.DE (hold): Viromed remains a high-risk technological special situation centered on PulmoPlas: a convincing peer-reviewed publication supports a €250-450M enterprise-value scenario, while clinically relevant human results could support €0.8-1.5B. Current evidence remains preclinical, and 2026 guidance was reduced; failed clinical translation, safety or regulatory setbacks, financing needs and dilution could invalidate much of the thesis.
Read full article (13 min)